Intervention | Ref | VAP incidence (per 1000 patients) | Mortality incidence (per 1000 patients) | ||||||
---|---|---|---|---|---|---|---|---|---|
Control | Intervention | RR; (95% CI) | n/N | Control | Intervention | RR; (95% CI) | n/N | ||
Semi-recumbent b | [20] | 316 | 139 | 0·44; 0·11–1·77 | 3/419 | 276 | 240 | 0·87; 0·59–1·27 | 2/307 |
HME c | [21] | 167 | 155 | 0·93; 0·73–1·19 | 13/2251 | 247 | 257 | 1·03; 0·89–1·2 | 12/1951 |
Probiotic d | [22] | 309 | 238 | 0·7; 0·52–0·95 | 8/1018 | 214 | 186 | 0·84; 0·58–1·22 | 5/703 |
Chlorhexidine e | [23] | 243 | 180 | 0·75; 0·62–0·91 | 18/2451 | 222 | 242 | 1·09; 0·96–1·23 | 14/2014 |
Tooth brushing f | [23] | 253 | 206 | 0·69; 0·44–1·09 | 5/889 | 269 | 237 | 0·87; 0·7–1·09 | 5/889 |
TAP + PPAP g | [1] | 417 | 179 | 0·43; 0·35–0·53 | 17/2951 | 303 | 255 | 0·84; 0·73–0·96 | 18/5290 |
TAP (alone) h | [1] | 324 | 162 | 0·50; 0·36–0·69 | 13/1848 | 305 | 296 | 0·97; 0·87–1·07 | 15/3274 |
TAP + PPAP (versus PPAP) i, j | [1] | 303 | 278 | 0·82; 0·58–1·16 | 6/247 | 237 | 221 | 0·92; 0·72–1·18 | 7/1039 |